Edgewell Personal Care Company (EPC) Financials

EPS

Hollow marker is the consensus estimate; filled is the reported figure, colored by beat or miss.

Revenue

Outlined bar is the consensus estimate; solid is reported.

Results

Periods without a consensus estimate or a reported figure show a dash.

Period	EPS estimate	EPS actual	EPS surprise %	Revenue estimate	Revenue actual	Revenue surprise %
Q3 26	$0.61	$0.72	+18.0%	—	$570.1M	—
Q2 26	$0.44	$0.6	+36.4%	—	$519.5M	—
Q1 26	-$0.16	-$0.16	0.0%	—	$422.8M	—
Q4 25	$0.81	$0.68	-16.0%	—	$537.2M	—
Q3 25	$0.99	$0.92	-7.1%	—	—	—
Q2 25	$0.91	$0.87	-4.4%	—	—	—
Q1 25	$0.12	$0.07	-41.7%	—	—	—
Q4 24	$0.67	$0.72	+7.5%	—	—	—
Q3 24	$1.01	$1.22	+20.8%	—	—	—
Q2 24	$0.72	$0.88	+22.2%	—	—	—
Q1 24	$0.06	$0.24	+300.0%	—	—	—
Q4 23	$0.64	$0.72	+12.5%	—	—	—
Q3 23	$0.81	$0.98	+21.0%	—	$650M	—
Q2 23	$0.35	$0.56	+60.0%	—	$598.4M	—
Q1 23	$0.21	$0.31	+47.6%	—	$469.1M	—
Q4 22	$0.76	$0.79	+3.9%	—	$536.9M	—

EPS

Reported per-share earnings by fiscal year; the line turns dotted where reported figures end and the analyst consensus begins, with the shaded band marking the low–high range.

Revenue

Reported revenue by fiscal year; the line turns dotted where reported figures end and the analyst consensus begins, with the shaded band marking the low–high range.

Results

Periods without a consensus estimate or a reported figure show a dash.

Period	EPS estimate	EPS actual	EPS surprise %	Revenue estimate	Revenue actual	Revenue surprise %
FY25	—	$0.53	—	—	$2.2B	—
FY24	—	$1.98	—	—	$2.3B	—
FY23	—	$2.21	—	—	$2.3B	—
FY22	—	$1.86	—	—	$2.2B

Total revenue

Reported revenue per period; the line is the change from the same period a year earlier, on its own left axis.

Period	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Revenue	$2.4B	$2.3B	$2.2B	$2.1B	$1.9B	$2.1B	$2.2B	$2.3B	$2.3B	$2.2B
YoY change	-2.45%	-2.69%	-2.78%	-4.18%	-8.94%	+7.06%	+4.04%	+3.68%	+0.09%	-1.34%

Revenue and profits

Revenue, gross profit, operating income, and net income per period.

Condensed income statement

Click a row to chart it; unreported figures show a dash.

Period	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Revenue	2.4B	2.3B	2.2B	2.1B	1.9B	2.1B	2.2B	2.3B	2.3B	2.2B
Cost of revenue	1.2B	1.2B	1.2B	1.2B	1.1B	1.1B	1.3B	1.3B	1.3B	1.3B
Gross profit	1.2B	1.1B	1B	966.6M	880.9M	951.2M	880.5M	940.8M	955.7M	924.9M
Gross margin	49.1%	49%	46.2%	45.1%	45.2%	45.6%	40.5%	41.8%	42.4%	41.6%
Research & development	71.9M	67.6M	61.1M	53.5M	55.3M	57.8M	55.5M	58.5M	58.4M	57.6M
Selling, general & administrative	749.4M	710.8M	688.4M	622.9M	625M	632.7M	627.4M	638.7M	662.1M	671.7M
Operating expenses	821.3M	778.4M	749.5M	676.4M	680.3M	690.5M	682.9M	697.2M	720.5M	729.3M
Operating income	338.6M	347.5M	283.4M	290.2M	200.6M	260.7M	197.6M	243.6M	235.2M	195.6M
Operating margin	14.3%	15.1%	12.7%	13.6%	10.3%	12.5%	9.1%	10.8%	10.4%	8.8%
Non-operating income, net	-46.9M	-331.2M	-51.6M	-617.9M	-52.1M	-45.7M	-2.1M	-17.4M	-37.8M	-98.8M
Pretax income	219.9M	-52.9M	163.8M	-390.3M	87.3M	147.1M	124.1M	147.7M	120.9M	23.6M
Income tax	41.2M	-58.6M	60.5M	-18.1M	19.7M	29.3M	24.6M	33M	22.3M	-1.8M
Net income	178.7M	5.7M	103.3M	-372.2M	67.6M	117.8M	99.5M	114.7M	98.6M	25.4M
Net margin	7.57%	0.25%	4.62%	-17.4%	3.47%	5.64%	4.58%	5.09%	4.38%	1.14%
EBITDA	428M	459.3M	382.4M	382.5M	284M	349M	300.7M	334.2M	321.3M	284.6M
EPS	3.02	0.1	1.9	-6.52	1.25	2.15	1.86	2.21	1.98	0.53
Diluted EPS	2.99	0.1	1.9	-6.52	1.24	2.12	1.84	2.18	1.97	0.53

Revenue and profits

Revenue, gross profit, operating income, and net income per period.

Condensed income statement

Click a row to chart it; unreported figures show a dash.

Period	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26	Q3 26
Revenue	—	—	—	—	—	—	—	—	537.2M	422.8M	519.5M	570.1M
Cost of revenue	—	—	—	—	—	—	—	—	328.6M	261.8M	302.6M	327.6M
Gross profit	—	—	—	—	—	—	—	—	208.6M	161M	216.9M	242.5M
Gross margin	—	—	—	—	—	—	—	—	38.8%	38.1%	41.8%	42.5%
Research & development	—	—	—	—	—	—	—	—	15.8M	13.8M	14.9M	13.3M
Selling, general & administrative	—	—	—	—	—	—	—	—	162.5M	148M	169.6M	191.5M
Operating expenses	—	—	—	—	—	—	—	—	178.3M	161.8M	184.5M	204.8M
Operating income	—	—	—	—	—	—	—	—	30.3M	-800K	32.4M	37.7M
Operating margin	—	—	—	—	—	—	—	—	5.64%	-0.19%	6.24%	6.61%
Non-operating income, net	—	—	—	—	—	—	—	—	-66.9M	-16.8M	-6.6M	-12.7M
Pretax income	—	—	—	—	—	—	—	—	-53.2M	-36.9M	7.9M	18M
Income tax	—	—	—	—	—	—	—	—	-22.6M	-7.7M	3.9M	5.7M
Net income	—	—	—	—	—	—	—	—	-30.6M	-29.2M	-10.6M	13.7M
Net margin	—	—	—	—	—	—	—	—	-5.7%	-6.91%	-2.04%	2.4%
EBITDA	—	—	—	—	—	—	—	—	49.6M	21.8M	58.9M	75.7M
EPS	0.58	0.1	0.72	0.99	0.18	-0.04	0.6	0.62	-0.66	-1.41	-0.23	0.3
Diluted EPS	0.57	0.09	0.72	0.98	0.17	-0.04	0.6	0.62	-0.66	-1.41	-0.23	0.29

P/E

Annual history by fiscal year; click a table row below to chart a different metric.

Current values are trailing twelve months where available, otherwise the latest fiscal year; unreported figures show a dash.

Key stats

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Market cap	4.7B	4.2B	2.5B	1.8B	1.5B	2B	2B	1.9B	1.8B	967.1M	1.3B
Enterprise value	5.8B	5.2B	3.5B	2.6B	2.5B	2.8B	3.2B	3.1B	2.9B	2.2B	2.2B
Shares outstanding	59.2M	57.3M	54.4M	54.1M	54.3M	54.4M	53.1M	51.2M	49.7M	47.5M	47.5M

Valuation

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
P/E	26.3	731.5	24.3	—	22.4	16.8	20	16.5	18.3	38.1	201.8
P/S	1.99	1.81	1.13	0.82	0.78	0.95	0.91	0.84	0.8	0.43	0.57
P/B	2.57	2.39	1.44	1.35	1.06	1.25	1.35	1.23	1.14	0.62	0.88
EV/EBITDA	13.6	11.3	9.27	6.92	8.63	8.06	10.7	9.14	9.01	7.57	8.22
EV/Sales	2.46	2.27	1.59	1.24	1.26	1.35	1.48	1.36	1.29	0.97	0.96
Earnings yield	3.8%	0.14%	4.11%	—	4.47%	5.97%	5.01%	6.06%	5.46%	2.63%	0.5%
FCF yield	2.49%	5.87%	7.85%	7.54%	12.2%	8.72%	2.3%	8.8%	9.66%	4.28%	18.5%
PEG	—	—	—	—	—	—	—	—	—	—	-3.91

Profitability

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Gross margin	49.1%	49%	46.2%	45.1%	45.2%	45.6%	40.5%	41.8%	42.4%	41.6%	42.5%
Operating margin	14.3%	15.1%	12.7%	13.6%	10.3%	12.5%	9.1%	10.8%	10.4%	8.8%	8.8%
Net margin	7.57%	0.25%	4.62%	-17.4%	3.47%	5.64%	4.58%	5.09%	4.38%	1.14%	-4.15%
ROE	9.77%	0.33%	5.92%	-28.6%	4.72%	7.44%	6.78%	7.45%	6.22%	1.64%	-1.29%
ROA	3.75%	0.14%	2.61%	-10.9%	1.91%	3.21%	2.68%	3.07%	2.64%	0.68%	2.97%
ROIC	9.38%	12.5%	6.44%	13.2%	6.55%	8.61%	5.89%	7%	7.17%	7.14%	4.25%
Return on tangible assets	-21.3%	-0.67%	-9.01%	79.1%	-10.7%	-25.4%	-10.8%	-13.2%	-11.7%	-3.8%	16.4%

Financial health

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Current ratio	1.67	2.26	1.33	1.58	1.93	2.12	1.75	1.84	1.66	1.76	1.84
Quick ratio	1.32	1.63	0.87	1.04	1.31	1.47	0.91	0.9	0.81	0.9	1.12
Debt / equity	1.01	0.89	0.74	0.94	0.91	0.83	0.96	0.9	0.82	0.91	0.88
Debt / assets	0.39	0.37	0.33	0.36	0.37	0.36	0.38	0.37	0.35	0.38	0.36
Net debt / EBITDA	2.58	2.27	2.69	2.32	3.3	2.41	4.06	3.48	3.39	4.17	4.28
Interest coverage	4.06	0.24	3.41	-5.23	2.43	3.17	2.74	2.88	2.58	1.32	0.07
Effective tax rate	18.7%	0%	36.9%	0%	22.6%	19.9%	19.8%	22.3%	18.4%	0%	0%

Per share

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Revenue per share	39.9	40.1	41.1	39.6	35.9	38.4	40.9	44	45.3	46.8	48.3
EPS (basic)	3.02	0.1	1.9	-6.52	1.25	2.15	1.86	2.21	1.98	0.53	0.53
EPS (diluted)	2.99	0.1	1.9	-6.52	1.24	2.12	1.84	2.18	1.97	0.53	-0.42
Book value per share	30.9	30.4	32.1	24.1	26.4	29.1	27.6	30.1	31.9	32.7	31.7
FCF per share	1.98	4.27	3.63	2.45	3.41	3.17	0.86	3.25	3.51	0.87	1.12
Cash per share	12.5	8.78	4.9	6.31	6.72	8.81	3.55	4.23	4.21	4.75	8.62
Capex per share	—	—	0.35	0	0	—	—	—	—	1.62	1.48

Capital allocation

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Capex / revenue	—	—	0.85%	0%	0%	—	—	—	—	3.46%	3.36%
Capex / operating cash flow	—	—	7.73%	0%	0%	—	—	—	—	65%	56.8%
Payout ratio	0%	0%	—	0%	0%	21.7%	32.8%	27.5%	31.1%	115.4%	545.5%
Dividend yield	0%	0%	—	0%	0%	1.3%	1.64%	1.66%	1.7%	3.03%	2.12%

Yield

2.12%

trailing twelve months

Frequency

Quarterly

Last dividend

$0.15

ex-dividend Sep 9, 2026

Payout ratio

545%

of earnings

Dividend growth

0 years

consecutive annual raises

Dividend per share

Split-adjusted payout per share by ex-dividend date.

Recent payouts

Ex-dividend	Amount
Sep 9, 2026	$0.15
Jun 10, 2026	$0.15
Mar 6, 2026	$0.15
Dec 4, 2025	$0.15
Sep 4, 2025	$0.15
Jun 6, 2025	$0.15
Mar 5, 2025	$0.15
Dec 3, 2024	$0.15

Period	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26	Q3 26
Revenue	—	—	—	—	—	—	—	—	$537.2M	$422.8M	$519.5M	$570.1M
YoY change	—	—	—	—	—	—	—	—	—	—	—	—

Assets vs. liabilities & equity

What the company owns (left stack) against what it owes plus shareholders' equity (right stack). The two stacks should match — that's the balance.

Condensed balance sheet

Click a row to chart it; unreported figures show a dash.

Period	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Cash & short-term investments	738.9M	502.9M	266.4M	341.6M	364.7M	479.2M	188.7M	216.4M	209.1M	225.7M
Receivables	260.7M	224.1M	226.5M	205.6M	158.8M	150.7M	136.9M	106.2M	109.4M	137.8M
Inventory	309.2M	333.5M	329.5M	357.2M	314.1M	345.7M	449.3M	492.4M	477.3M	484.7M
Total current assets	1.5B	1.2B	951.2M	1B	983.6M	1.1B	942.2M	962.4M	936M	995.5M
Property, plant & equipment	340.1M	314.3M	282.2M	258.6M	228.7M	218.1M	205.2M	195.3M	201.2M	216.2M
Goodwill & intangibles	5.6B	5B	5.1B	3.9B	4.2B	4.1B	4.6B	4.6B	4.6B	4.4B
Total assets	4.8B	4.2B	4B	3.4B	3.5B	3.7B	3.7B	3.7B	3.7B	3.8B
Accounts payable	196.5M	223.6M	238.4M	222.8M	181.9M	209.5M	228.8M	194.4M	219.3M	219.7M
Short-term debt	300.3M	19.4M	193.1M	131.4M	30.2M	37.5M	19M	19.5M	24.5M	29.5M
Total current liabilities	868.2M	524.4M	717M	659.6M	510.5M	536.8M	539.5M	523.4M	563.6M	565.5M
Long-term debt	1.5B	1.5B	1.1B	1.1B	1.3B	1.3B	1.4B	1.4B	1.3B	1.4B
Total liabilities	2.9B	2.4B	2.2B	2.1B	2.1B	2.1B	2.2B	2.2B	2.1B	2.2B
Shareholders' equity	1.8B	1.7B	1.7B	1.3B	1.4B	1.6B	1.5B	1.5B	1.6B	1.6B
Total debt	1.8B	1.5B	1.3B	1.2B	1.3B	1.3B	1.4B	1.4B	1.3B	1.4B
Net debt	1.1B	1B	1B	887.6M	938M	839.4M	1.2B	1.2B	1.1B	1.2B

Assets vs. liabilities & equity

What the company owns (left stack) against what it owes plus shareholders' equity (right stack). The two stacks should match — that's the balance.

Condensed balance sheet

Click a row to chart it; unreported figures show a dash.

Period	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26	Q3 26
Cash & short-term investments	216.4M	214.2M	196.2M	196.1M	209.1M	175.5M	170.1M	199.6M	225.7M	223.3M	299.7M	397.1M
Receivables	106.2M	112.5M	130.6M	155M	109.4M	120.5M	178.2M	153.2M	137.8M	154M	185.4M	119.4M
Inventory	492.4M	521.9M	496.4M	455.9M	477.3M	501.6M	512.2M	488.4M	484.7M	461.2M	450.1M	433M
Total current assets	962.4M	1B	994.8M	958.7M	936M	945.2M	1B	1B	995.5M	1.1B	1.1B	1.1B
Property, plant & equipment	195.3M	188.6M	183.2M	181.2M	201.2M	196.8M	196.6M	204.1M	216.2M	176.3M	173.7M	179.9M
Goodwill & intangibles	4.6B	4.6B	4.6B	4.6B	4.6B	4.5B	4.5B	4.5B	4.4B	3.9B	3.9B	3.9B
Total assets	3.7B	3.8B	3.8B	3.7B	3.7B	3.7B	3.8B	3.8B	3.8B	3.8B	3.5B	3.5B
Accounts payable	194.4M	197.5M	219.7M	208.7M	219.3M	203.8M	215.6M	224.5M	219.7M	213.1M	231.1M	230.7M
Short-term debt	19.5M	24.2M	23.6M	21.4M	24.5M	27.2M	43.9M	39.5M	29.5M	32.5M	35.1M	34.2M
Total current liabilities	523.4M	467.7M	541.9M	535.1M	563.6M	459M	536.3M	567.4M	565.5M	497.5M	613.8M	603.6M
Long-term debt	1.4B	1.5B	1.4B	1.3B	1.3B	1.4B	1.4B	1.4B	1.4B	1.5B	1.2B	1.2B
Total liabilities	2.2B	2.2B	2.2B	2.1B	2.1B	2.2B	2.3B	2.2B	2.2B	2.3B	2.1B	2.1B
Shareholders' equity	1.5B	1.5B	1.6B	1.6B	1.6B	1.5B	1.5B	1.6B	1.6B	1.5B	1.4B	1.5B
Total debt	1.4B	1.5B	1.4B	1.3B	1.3B	1.5B	1.5B	1.4B	1.4B	1.6B	1.3B	1.3B
Net debt	1.2B	1.3B	1.2B	1.1B	1.1B	1.3B	1.3B	1.2B	1.2B	1.3B	979.8M	882.1M

Cash generation and uses

Cash from operations, what's left after capex, and what went back to shareholders. Bars below the line are cash going out.

Condensed cash flow statement

Click a row to chart it; unreported figures show a dash.

Period	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Net income	178.7M	5.7M	103.3M	-372.2M	67.6M	117.8M	99.5M	114.7M	98.6M	25.4M
Depreciation & amortization	92.6M	94.4M	97.6M	93.8M	88.8M	87.1M	89.9M	91.4M	88M	88.8M
Stock-based compensation	25.6M	22.2M	17M	17.8M	19.2M	27.3M	23.8M	27.5M	26.5M	24.5M
Change in working capital	-8.1M	-3.3M	-4.2M	-47.5M	43.2M	-28M	-82.1M	5M	47.6M	-25.8M
Operating cash flow	279.7M	-9.2M	245.9M	-380.9M	208.2M	202M	100.5M	205.7M	230.3M	118.4M
Capital expenditure	—	—	19M	0	0	—	—	—	—	-77M
Investing cash flow	0	-15.6M	-56.8M	12.5M	-148.7M	8.1M	-299M	-1M	-5.9M	-72.9M
Dividends paid	0	0	—	0	0	-25.6M	-32.6M	-31.5M	-30.7M	-29.3M
Share repurchases	-196.6M	-165.4M	-124.4M	0	0	-9.2M	-125.3M	-75.2M	-58.5M	-90.2M
Financing cash flow	-93.4M	-478M	-379.6M	-63.8M	731.3M	-65.4M	-17.6M	-146.5M	-179.4M	-30M
Net change in cash	186.3M	-502.8M	-190.5M	-432.2M	790.8M	144.7M	-216.1M	58.2M	45M	15.5M
Free cash flow	117.3M	244.6M	197.4M	132.6M	184.9M	172.2M	45.6M	166.6M	174.5M	41.4M

Cash generation and uses

Cash from operations, what's left after capex, and what went back to shareholders. Bars below the line are cash going out.

Condensed cash flow statement

Click a row to chart it; unreported figures show a dash.

Period	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26	Q3 26
Net income	31.3M	4.8M	36M	49M	8.8M	-2.1M	29M	29.1M	-30.6M	-65.7M	-10.6M	13.7M
Depreciation & amortization	23.3M	22.5M	22.4M	21.7M	21.4M	21.7M	21.8M	22.1M	23.2M	21.3M	19.1M	18.6M
Stock-based compensation	7.7M	7M	6.3M	7.1M	6.1M	6.1M	6.3M	6.4M	5.7M	3.4M	5.6M	5.7M
Change in working capital	—	—	—	—	—	—	—	—	—	—	—	—
Operating cash flow	48.5M	33.1M	58.9M	73.5M	17.2M	28M	44.8M	114.8M	74.1M	-125.9M	54.3M	118.7M
Capital expenditure	—	—	—	—	—	—	—	-15.5M	-27.6M	-11.6M	-14M	-15.6M
Investing cash flow	-500K	500K	-2.2M	-4.6M	400K	1.1M	-200K	-12.3M	-27.6M	-9.9M	-13.9M	-14.1M
Dividends paid	-7.7M	-7.6M	-8.2M	-7.5M	-7.4M	-7.9M	-7.3M	-7.2M	-6.9M	-7.4M	-7.1M	-7M
Share repurchases	-30M	-15M	-15.3M	-9.9M	-18.3M	-30.3M	-35.4M	-24.5M	0	0	-15.8M	0
Financing cash flow	-14.2M	69.8M	-129.2M	-79.9M	-40.1M	109.9M	-37.4M	-84.2M	-18.3M	133.4M	-300.8M	-7.3M
Net change in cash	33.8M	103.4M	-72.5M	-11M	-22.5M	139M	7.2M	18.3M	28.2M	-2.4M	-260.4M	97.3M
Free cash flow	29.4M	-79.4M	117.5M	88.6M	47.8M	-132.4M	28M	99.3M	46.5M	-137.5M	40.3M	103.1M

Edgewell Personal Care Company Financials

EPS

Revenue

Results

EPS

Revenue

Results

Total revenue

Total revenue

Revenue and profits

Condensed income statement

Revenue and profits

Condensed income statement

P/E

Key stats

Valuation

Profitability

Financial health

Per share

Capital allocation

Dividend per share

Recent payouts

Assets vs. liabilities & equity

Condensed balance sheet

Assets vs. liabilities & equity

Condensed balance sheet

Cash generation and uses

Condensed cash flow statement

Cash generation and uses

Condensed cash flow statement

Split history